A method to integrate benchmark dose estimates with genomic data to assess the functional effects of chemical exposure.

The use of genomic technology for assessing health risks associated with chemical exposure has significant potential, but its direct application has proven to be challenging for the toxicology and risk assessment communities. In this study, a method was established for analyzing dose-response microarray data using benchmark dose (BMD) calculations and gene ontology (GO) classification. Gene expression changes in the rat nasal epithelium following acute formaldehyde exposure were used as a case study. The gene expression data were first analyzed using a one-way ANOVA to identify genes that showed significant dose-response behavior. These genes were then fit to a series of four statistical models (linear, second-degree polynomial, third-degree polynomial, and power models) and the least complex model that best described the data was selected. The genes were matched to their associated GO categories, and the average BMD and benchmark dose lower confidence limit (BMDL) were calculated for each GO category. The results were used to identify doses at which individual cellular processes were altered. For the formaldehyde exposures, the BMD estimates for the GO categories related to cell proliferation and DNA damage were similar to those measured in previous studies using cell labeling indices and DNA-protein cross-links and consistent with the BMD estimated for rat nasal tumors. The method represents a significant advance in applying genomic information to risk assessment by allowing a comprehensive survey of molecular changes associated with chemical exposure and providing the capability to identify reference doses at which particular cellular processes are altered.

[1]  R. Hertzberg,et al.  A new method for determining allowable daily intakes. , 1986, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[2]  Vincent Cogliano,et al.  Formaldehyde and Glutaraldehyde and Nasal Cytotoxicity: Case Study Within the Context of the 2006 IPCS Human Framework for the Analysis of a Cancer Mode of Action for Humans , 2006, Critical reviews in toxicology.

[3]  Paul M Schlosser,et al.  Benchmark dose risk assessment for formaldehyde using airflow modeling and a single-compartment, DNA-protein cross-link dosimetry model to estimate human equivalent doses. , 2003, Risk analysis : an official publication of the Society for Risk Analysis.

[4]  Hanlee P. Ji,et al.  The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. , 2006, Nature biotechnology.

[5]  O R Moss,et al.  DNA-protein cross-links and cell replication at specific sites in the nose of F344 rats exposed subchronically to formaldehyde. , 1994, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[6]  Kristina Hanspers,et al.  A system-based approach to interpret dose- and time-dependent microarray data: quantitative integration of gene ontology analysis for risk assessment. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[7]  Wayne Spoo,et al.  Toxicological profile for formaldehyde , 1999 .

[8]  Kenny S. Crump,et al.  Calculation of Benchmark Doses from Continuous Data , 1995 .

[9]  H. Akaike,et al.  Information Theory and an Extension of the Maximum Likelihood Principle , 1973 .

[10]  Yudong D. He,et al.  Functional Discovery via a Compendium of Expression Profiles , 2000, Cell.

[11]  P. Foster,et al.  Distinguishing between adverse and non-adverse effects. Session summary. , 2002, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[12]  Julia S Kimbell,et al.  Biologically motivated computational modeling of formaldehyde carcinogenicity in the F344 rat. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[13]  Cees de Heer,et al.  Inhaled formaldehyde: evaluation of sensory irritation in relation to carcinogenicity. , 2006, Regulatory toxicology and pharmacology : RTP.

[14]  Longlong Yang,et al.  Genome-wide analysis of human HSF1 signaling reveals a transcriptional program linked to cellular adaptation and survival. , 2006, Molecular bioSystems.

[15]  P. Foster,et al.  Endocrine Active Agents: Implications of Adverse and Non-Adverse Changes , 2002, Toxicologic pathology.

[16]  Maqc Consortium.  The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements , 2006, Nature Biotechnology.

[17]  K T Morgan,et al.  Regional increases in rat nasal epithelial cell proliferation following acute and subchronic inhalation of formaldehyde. , 1991, Toxicology and applied pharmacology.

[18]  Richard W. Lewis,et al.  Recognition of Adverse and Nonadverse Effects in Toxicity Studies , 2002, Toxicologic pathology.

[19]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[20]  Nils Lid Hjort,et al.  Model Selection and Model Averaging , 2001 .

[21]  Purvesh Khatri,et al.  Onto-Tools: an ensemble of web-accessible, ontology-based tools for the functional design and interpretation of high-throughput gene expression experiments , 2004, Nucleic Acids Res..

[22]  Hiroaki Kitano,et al.  Biological robustness , 2008, Nature Reviews Genetics.

[23]  T. Speed,et al.  GOstat: find statistically overrepresented Gene Ontologies within a group of genes. , 2004, Bioinformatics.

[24]  T. Starr,et al.  More precise localization of nasal tumors associated with chronic exposure of F-344 rats to formaldehyde gas. , 1986, Toxicology and applied pharmacology.

[25]  D. Rank,et al.  Application of genomics to toxicology research. , 2002, Environmental health perspectives.

[26]  H. Heck,et al.  Covalent binding of inhaled formaldehyde to DNA in the nasal mucosa of Fischer 344 rats: analysis of formaldehyde and DNA by high-performance liquid chromatography and provisional pharmacokinetic interpretation. , 1989, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[27]  D. Gaylor,et al.  Role of the Standard Deviation in the Estimation of Benchmark Doses with Continuous Data , 2004, Risk analysis : an official publication of the Society for Risk Analysis.

[28]  Bing Zhang,et al.  GOTree Machine (GOTM): a web-based platform for interpreting sets of interesting genes using Gene Ontology hierarchies , 2004, BMC Bioinformatics.

[29]  T. Speed,et al.  Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.

[30]  J A Swenberg,et al.  Correlation of regional and nonlinear formaldehyde-induced nasal cancer with proliferating populations of cells. , 1996, Cancer research.

[31]  H. Kitano,et al.  Robustness trade-offs and host–microbial symbiosis in the immune system , 2006, Molecular systems biology.

[32]  G. Orphanides,et al.  Mapping molecular responses to xenoestrogens through Gene Ontology and pathway analysis of toxicogenomic data. , 2005, Reproductive toxicology.

[33]  K T Morgan,et al.  Application of computational fluid dynamics to regional dosimetry of inhaled chemicals in the upper respiratory tract of the rat. , 1993, Toxicology and applied pharmacology.

[34]  Gary M Williams,et al.  Distinguishing between Adverse and Non-Adverse Effects , 2001 .

[35]  Salomon Sand,et al.  The Benchmark Dose Method—Review of Available Models, and Recommendations for Application in Health Risk Assessment , 2003, Critical reviews in toxicology.

[36]  C. Travis,et al.  The Genomic Revolution: What Does it Mean for Human and Ecological Risk Assessment? , 2003, Ecotoxicology.

[37]  David Botstein,et al.  Diverse and specific gene expression responses to stresses in cultured human cells. , 2004, Molecular biology of the cell.

[38]  J A Swenberg,et al.  Carcinogenicity of formaldehyde in rats and mice after long-term inhalation exposure. , 1983, Cancer research.

[39]  D. Posada,et al.  Model selection and model averaging in phylogenetics: advantages of akaike information criterion and bayesian approaches over likelihood ratio tests. , 2004, Systematic biology.

[40]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .